Literature DB >> 20433031

Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model.

David R Holtgrave1.   

Abstract

Recent estimates show that the transmission rate of human immunodeficiency virus (HIV) in the U.S. has substantially decreased. This raises the question, is elimination of HIV infection in the nation feasible in the foreseeable future? We demonstrate that if the HIV transmission rate were reduced by 50%, then the reproductive rate of HIV infection would drop below unity and lead to eventual elimination of infection. In recent congressional testimony, the director of the Centers for Disease Control and Prevention and others asserted that the HIV transmission rate can be halved by 2020, if not earlier, provided sufficient investment is made toward achieving this goal. We assert that if adequate investment is made and the transmission rate is in fact lowered by 50%, then the HIV reproductive rate would fall below unity, setting the stage for eventual elimination of HIV infection in the U.S.

Entities:  

Mesh:

Year:  2010        PMID: 20433031      PMCID: PMC2848261          DOI: 10.1177/003335491012500305

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  17 in total

1.  Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA.

Authors:  Gary Marks; Nicole Crepaz; Robert S Janssen
Journal:  AIDS       Date:  2006-06-26       Impact factor: 4.177

2.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

Authors:  Reuben M Granich; Charles F Gilks; Christopher Dye; Kevin M De Cock; Brian G Williams
Journal:  Lancet       Date:  2008-11-27       Impact factor: 79.321

3.  Updated annual HIV transmission rates in the United States, 1977-2006.

Authors:  David Holtgrave; H Irene Hall; Philip H Rhodes; Richard Wolitski
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

4.  Universal voluntary HIV testing and immediate antiretroviral therapy.

Authors:  David P Wilson
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

5.  Universal voluntary HIV testing and immediate antiretroviral therapy.

Authors:  Allison Ruark; James D Shelton; Daniel T Halperin; Maria J Wawer; Ronald H Gray
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

6.  Universal voluntary HIV testing and immediate antiretroviral therapy.

Authors:  Myron S Cohen; Timothy D Mastro; Willard Cates
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

7.  Universal voluntary HIV testing and immediate antiretroviral therapy.

Authors:  Helen Epstein
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

8.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

9.  HIV prevalence estimates--United States, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-10-03       Impact factor: 17.586

10.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

Authors: 
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

View more
  8 in total

1.  It is too early to discuss HIV elimination.

Authors:  David P Wilson; Sean R Hosein
Journal:  Public Health Rep       Date:  2010 Nov-Dec       Impact factor: 2.792

2.  Estimating the number of young Black men who have sex with men (YBMSM) on the south side of Chicago: towards HIV elimination within US urban communities.

Authors:  Britt Livak; Stuart Michaels; Keith Green; Charles Nelson; Montre Westbrook; Yaa Simpson; Nikhil G Prachand; Nanette Benbow; John A Schneider
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

Review 3.  HIV transmission rate modeling: a primer, review, and extension.

Authors:  Steven D Pinkerton
Journal:  AIDS Behav       Date:  2012-05

Review 4.  Combination HIV prevention: significance, challenges, and opportunities.

Authors:  Ann E Kurth; Connie Celum; Jared M Baeten; Sten H Vermund; Judith N Wasserheit
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

5.  A new HIV prevention network approach: sociometric peer change agent selection.

Authors:  John A Schneider; A Ning Zhou; Edward O Laumann
Journal:  Soc Sci Med       Date:  2014-01-31       Impact factor: 4.634

6.  HIV Transmission Rates in the United States, 2006-2008.

Authors:  David R Holtgrave; H Irene Hall; Joseph Prejean
Journal:  Open AIDS J       Date:  2012-03-30

Review 7.  HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention.

Authors:  David P Wilson
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

8.  Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis.

Authors:  Vimalanand S Prabhu; Paul G Farnham; Angela B Hutchinson; Sada Soorapanth; James D Heffelfinger; Matthew R Golden; John T Brooks; David Rimland; Stephanie L Sansom
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.